Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Helmvacc
PACTR201303000434188Unknown
- Sponsor
- Dr. Ayola Akim Adegnika, MD, PhD
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of albendazole in Helminthiases, sponsored by Dr. Ayola Akim Adegnika, MD, PhD. Primary endpoint: Antibody titer to vaccine antigens. Status: unknown.
02
Drugs
albendazole
03
Conditions
Helminthiases
Beyond the preview
Go deeper on PACTR201303000434188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201303000434188.